Mail us for any queries

vls-pen@protonmail.com

#1 Weight Loss Medication

How it works?

VLS Tirzepatide works by mimicking the GLP-1 and GIP hormones that are naturally secreted by the intestine after a meal, which prompts insulin secretion.

VLS Tirzepatide also reduces appetite by slowing down the time it takes the stomach to empty and interacting with areas in the brain harboring GLP-1 receptors to signal satiety.

VLS Tirzepatide
for Weightloss
  • FDA approved in 2023
  • Up to 24.6% weight loss over 72 week trials
  • Powerful apetite suppresant
  • Regulates blood sugar
  • Can help improve cardiovascular risk factors
  • Improves lipid levels
FAQs
Usage
Initial Dose Escalation Schedule

  • Weeks 1 through 4: 2.5 mg subcutaneously once a week
  • Weeks 5 through 8: 5 mg subcutaneously once a week
  • Weeks 9 through 12: 7.5 mg subcutaneously once a week
  • Weeks 13 through 16: 10 mg subcutaneously once a week
Maintenance Dose

  • Week 17 and onward: 10 mg subcutaneously once a week
Dosing Considerations

  • If dose escalation is not tolerated, consider delaying dose escalation for 4 weeks
  • Do not increase dose if desired results are achieved at a lower dose, most people maintain at 5mg per week
Instructions